Plain-English translation of NCT06930586 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether a new imaging-based tool called BRIDGE can predict survival outcomes in people with colorectal cancer. The study focuses on the connection between your brain and gut — an area scientists believe plays an important role in cancer development. If successful, this tool could help doctors better understand which patients may need different treatment approaches.
Colorectal cancer is a leading cause of cancer deaths worldwide, and doctors currently have limited tools to predict which patients will have better or worse outcomes. This research aims to fill that gap by exploring whether brain imaging can reveal patterns that help predict survival better than current methods.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning you won't receive a new medication or undergo a new procedure — researchers will review your existing medical records and imaging scans that were already done as part of your standard cancer care. You'll be asked to share your medical information and allow the study team to access your PET/CT images and health outcomes over time. Participation involves sharing data rather than attending multiple visits or undergoing additional tests.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China
~213 participants
Started
March 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yujie Bai
The First Affiliated Hospital of Zhengzhou University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.